Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope.

[1]  M Akhtar,et al.  Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. , 1991, Journal of the American College of Cardiology.

[2]  M Akhtar,et al.  Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. , 1991, Annals of internal medicine.

[3]  P. Tchou,et al.  Sequential catecholamine changes during upright tilt: Possible hormonal mechanisms responsible for pathogenesis of neurocardiogenic syncope , 1991 .

[4]  A. Fitzpatrick,et al.  TILTING TOWARDS A DIAGNOSIS IN RECURRENT UNEXPLAINED SYNCOPE , 1989, The Lancet.

[5]  C. Gornick,et al.  Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. , 1989, The New England journal of medicine.

[6]  F. Fouad-Tarazi,et al.  The Usefulness of Head‐Up Tilt Testing and Hemodynamic Investigations in the Workup of Syncope of Unknown Origin , 1988, Pacing and clinical electrophysiology : PACE.

[7]  B. Singh,et al.  Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings. , 1987, American heart journal.

[8]  V. Murthy,et al.  Esmolol and the Adrenergic Response to Perioperative Stimuli , 1986, Journal of clinical pharmacology.

[9]  B. Stults,et al.  Diagnostic evaluation of syncope. , 1986, The Western journal of medicine.

[10]  G O Barnett,et al.  Patients with syncope admitted to medical intensive care units. , 1982, JAMA.

[11]  M. Thames.  Effect of d- and l-propranolol on the discharge of cardiac vagal C fibers. , 1980, The American journal of physiology.

[12]  F. Abboud,et al.  Reflex control of the peripheral circulation. , 1976, Progress in cardiovascular diseases.

[13]  C. Regårdh,et al.  Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long‐term treatment , 1975, Clinical pharmacology and therapeutics.

[14]  T. Sjöstrand.  The regulation of the blood distribution in man. , 1952 .

[15]  Y. Zotterman,et al.  Depressor Reflexes from the Heart , 1948 .

[16]  D. Cameron,et al.  Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. , 1989, The American journal of cardiology.

[17]  P. Thorén,et al.  Role of cardiac vagal C-fibers in cardiovascular control. , 1979, Reviews of physiology, biochemistry and pharmacology.

[18]  A. V. Bezold.  Uber die physiologischen Wirkungen des essigsauren Veratrins , 1867 .